Clinical trial Recruiting at 1 site Interventional

Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates

Official title: Evaluating a Wireless NIRS Device in the Neonatal Intensive Care Unit: a Sub-study of the Wireless NICU Study

Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT07732244 · Data updated 2026-11-12

A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.

More Congenital Heart Disease trials

Quick facts

Study typeInterventional
SexAll
Enrollment20 (estimated)
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre
Academic / other
Locations1 site (Montreal, Quebec)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedAugust 1, 2026
Study endsDecember 1, 2026
Registry record updatedJuly 28, 2026
Trial IDNCT07732244 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants in the NICU at ≥32 weeks gestational age who are already monitored with the wired NIRS system and without skin conditions that increase injury risk.

Probably not a fit

Infants who do not meet the gestational age criteria or are too unstable for additional procedures may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests a wireless near-infrared spectroscopy sensor placed on the infant’s forehead for four hours over two consecutive days, alongside the standard wired NIRS sensor. The sensor is re-applied and timing of removal, re-application, and skin condition are recorded by the research team. The aim is to correlate signal disruption with nursing care events such as skin checks and sensor changes. Only infants meeting the eligibility criteria and stable enough for participation are included, with safety and skin integrity monitored. No control group is described as the focus is on sensor feasibility and data alignment with routine care.

Why it matters

Potential benefit: If successful, the approach could simplify monitoring workflows and reduce sensor-related skin issues while preserving data quality.

How similar studies have gone: Previous work has explored pediatric and neonatal sensors; this study adds feasibility data for a wireless approach in a clinical NICU setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants admitted to the NICU with a gestational age of ≥ 32 weeks at the time of the monitoring
* undergoing monitoring with the INVOS wired NIRS system.

Exclusion Criteria:

* Infants with a skin abnormality that would potentially increase the risk of injury,
* Patient too unstable or family experiencing too much stress as determined by an attending physician or bedside care team to not be approached for recruitment.

Where it's running

  • Montreal Children's Hospital
    Montreal, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.